Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model.

Viruses
Richard S BennettLisa E Hensley

Abstract

Ongoing Ebola virus disease outbreaks in the Democratic Republic of the Congo follow the largest recorded outbreak in Western Africa (2013-2016). To combat outbreaks, testing of medical countermeasures (therapeutics or vaccines) requires a well-defined, reproducible, animal model. Here we present Ebola virus disease kinetics in 24 Chinese-origin rhesus monkeys exposed intramuscularly to a highly characterized, commercially available Kikwit Ebola virus Filovirus Animal Non-Clinical Group (FANG) stock. Until reaching predetermined clinical disease endpoint criteria, six animals underwent anesthesia for repeated clinical sampling and were compared to six that did not. Groups of three animals were euthanized and necropsied on days 3, 4, 5, and 6 post-exposure, respectively. In addition, three uninfected animals served as controls. Here, we present detailed characterization of clinical and laboratory disease kinetics and complete blood counts, serum chemistries, Ebola virus titers, and disease kinetics for future medical countermeasure (MCM) study design and control data. We measured no statistical difference in hematology, chemistry values, or time to clinical endpoint in animals that were anesthetized for clinical sampling during ...Continue Reading

References

Jan 1, 1978·Transactions of the Royal Society of Tropical Medicine and Hygiene·E T BowenR T Raymond
Sep 5, 1998·The Journal of Infectious Diseases·M BrayJ Huggins
Feb 13, 1999·The Journal of Infectious Diseases·B M ConnollyP B Jahrling
Jan 19, 2002·Journal of Comparative Pathology·T R GibbN K Jaax
May 9, 2002·Emerging Infectious Diseases·Thomas W GeisbertPeter B Jahrling
Oct 19, 2011·The Journal of Infectious Diseases·Hideki EbiharaHeinz Feldmann
Nov 14, 2014·Journal of Virology·Gary WongGary P Kobinger
Sep 25, 2015·Emerging Infectious Diseases·Andrea MarziHeinz Feldmann
Nov 20, 2015·The Journal of Infectious Diseases·Brian H BirdChristina F Spiropoulou
Jun 30, 2016·The Journal of Infectious Diseases·Robert W CrossThomas W Geisbert
Sep 22, 2016·The Journal of Infectious Diseases·Gary WongGary Kobinger
Jun 8, 2018·The Journal of Infectious Diseases·Elaine HaddockAndrea Marzi
Jun 8, 2018·The Journal of Infectious Diseases·Gary WongXiangguo Qiu
Nov 2, 2018·MSphere·Marc-Antoine de La VegaGary P Kobinger
Sep 25, 2019·JCI Insight·Beatriz Escudero-PérezCésar Muñoz-Fontela

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Datasets Mentioned

BETA
MG572235.1

Methods Mentioned

BETA
PCR
blood collection
sedation

Software Mentioned

TIBCO
plus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JEMS : a Journal of Emergency Medical Services
James F Goss, Cynthia H Goss
Nature Reviews. Disease Primers
Relevé épidémiologique Hebdomadaire
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale
Kevin B Laupland, Louis Valiquette
Journal of the Chinese Medical Association : JCMA
Viroj Wiwanitkit
© 2021 Meta ULC. All rights reserved